Cap for an injection device
Latest Sanofi-Aventis Deutschland GMBH Patents:
- Drive mechanisms suitable for use in drug delivery devices
- USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTERS
- Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
- Processes for the preparation of (R)-?-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
- THE USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTER
Description
Claims
The ornamental design for a cap for an injection device, as shown and described.
Referenced Cited
U.S. Patent Documents
| 6575939 | June 10, 2003 | Brunel |
| D545364 | June 26, 2007 | Temovits |
| D650857 | December 20, 2011 | Lira-Nunez |
| D697205 | January 7, 2014 | Schneider |
| D708317 | July 1, 2014 | Schneider |
| D731051 | June 2, 2015 | Olson |
| D732161 | June 16, 2015 | Ohashi |
| D757255 | May 24, 2016 | Wohlfahrt |
| D758567 | June 7, 2016 | Wohlfahrt |
| D758569 | June 7, 2016 | Wohlfahrt |
| D773648 | December 6, 2016 | Wohlfahrt |
| D789528 | June 13, 2017 | Wohlfahrt |
| D793547 | August 1, 2017 | Burkett |
| D861799 | October 1, 2019 | Rapp et al. |
| D861859 | October 1, 2019 | Rapp et al. |
| D926967 | August 3, 2021 | Rogge |
| D931445 | September 21, 2021 | Jones |
| D934413 | October 26, 2021 | Nicholas |
| D944976 | March 1, 2022 | Bainton |
| D946141 | March 15, 2022 | Krulevitch |
| D948715 | April 12, 2022 | Hezkiahu |
| D951441 | May 10, 2022 | Murakami |
| D952835 | May 24, 2022 | Van Der Beek |
| D953526 | May 31, 2022 | Fournier |
| D953527 | May 31, 2022 | Fournier |
| D956211 | June 28, 2022 | Bourelle |
| D956212 | June 28, 2022 | Petersen |
| D956215 | June 28, 2022 | Krulevitch |
Patent History
Patent number: D988508
Type: Grant
Filed: Aug 12, 2019
Date of Patent: Jun 6, 2023
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main)
Inventors: Katrin Rapp (Frankfurt am Main), Oliver Greven (Frankfurt am Main), Marc Schader (Frankfurt am Main)
Primary Examiner: David G Muller
Application Number: 29/701,468
Type: Grant
Filed: Aug 12, 2019
Date of Patent: Jun 6, 2023
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main)
Inventors: Katrin Rapp (Frankfurt am Main), Oliver Greven (Frankfurt am Main), Marc Schader (Frankfurt am Main)
Primary Examiner: David G Muller
Application Number: 29/701,468
Classifications